Chromogenic Medium for Direct Susceptibility Testing of Candida spp. Isolated from Urine

Mycopathologia

Volumn 172, Issue 2, 2011, Pages 125-130

  de Vasconcelos Jr , Antônio Alexandre ^a,b   Menezes, Everardo Albuquerque ^a   Cunha, Francisco Afrânio ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Laboratory Research in Microbiology of Yeasts   (Brazil)

Author keywords

Antifungal susceptibility testing; Candida spp; Fluconazole

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ARTICLE; CANDIDA; CANDIDIASIS; CHEMISTRY; COMPARATIVE STUDY; CULTURE MEDIUM; DRUG EFFECT; EVALUATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; URINE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CULTURE MEDIA; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; URINE;

CANDIDA; CANDIDA ALBICANS;

EID: 79960574759     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9407-9     Document Type: Article

References (26)

1. Menezes EA, Mendes LG, Cunha FA. Resistência a antifúngicos de Candida tropicalis no Estado do Ceará. Rev Soc Bras Med Trop. 2009; 42: 354-5.
2. Pfaller MA, Diekema DJ. The epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007; 20: 133-63.
3. Cowen LE, Steinbach WJ. Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukariotic Cell. 2008; 7: 744-64.
4. Menezes EA, Monteiro MNR, Parente TMA, et al. Frequency and enzymatic activity of Candida albicans isolated from the oral cavity of HIV-positive patients at Fortaleza, Ceará. J Bras Patol Med Lab. 2006; 42: 253-6.
5. Araújo CR, Miranda KC, Passos XS, et al. Identificação das leveduras do gênero Candida por métodos manuais convencionais e pelo método cromógeno CHROMagar Candida. Rev Patologia Tropical. 2005; 34: 37-42.
6. Espinel-Ingroff A. Standardized disk diffusion method yeast. Clin Microb Newsl. 2007; 29: 97-100.
7. Rubio MC, Gil J, Ramirez OI, Benito R, Rezusta A. Comparison of results obtained by testing with three different agar media and by the NCCLS M27-A method for in vitro testing of fluconazole against Candida spp. J Clin Microbiol. 2003; 41: 2665-8.
8. Wayne PA. Clinical and Laboratory Standards Institute (CLSI). Methods for antifungal disk diffusion susceptibility testing of yeasts; approved standard M44-A. 1997.
9. Tan GL, Peterson EM. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures. J Clin Microbiology. 2005; 43: 1727-31.
10. García-Martos P, García-Agudo R, Hernándes-Molina JM, et al. Identification de leveduras de interés clínico en el medio de cultivo CHROMagar Candida. Rev Iberoam Micol. 1998; 15: 131-5.
11. ® diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media. Rev Iberoam Micol. 2008; 25: 215-20.
12. Kiraz N, Dag I, Oz Y, Yamac M, Kiremitci A, Kasifoglu N. Correlation between broth microdilution and disk difusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata. J Microbiol Meth. 2010; 82: 136-40.
13. Weinberger M, Sweet S, Leibovici L, Pitlik SD, Samra ZJ. Correlation between candiduria and departmental antibiotic use. J Hosp Infect. 2003; 53: 183-6.
14. Colombo AL, Guimarães T. Candiduria: a clinical and therapeutic approach. Rev Soc Bras Med Trop. 2007; 40: 332-7.
15. Hospenthal DR, Murray CK, Beckius L, Green JA, Dooley DP. Persistence of pigment production by yeast isolates grown on CHROMagar Candida medium. J Clin Microbiol. 2002; 40: 4768-70.
16. Huang L, Chen C, Chou C, et al. A comparison of methods for yeast identification including CHROMagar Candida, vitek system YBC and a traditional biochemical method. Chin Med J. 2001; 64: 568-74.
17. Silva EH, Ruiz LS, Matsumoto FE, et al. Candiduria in a public hospital of São Paulo (1999-2004): characteristics of the yeast isolates. Rev Inst Med Trop S. Paulo. 2007; 49: 349-53.
18. Chou H-H, Lo H-J, Chen K-W, Liao M-H, Li S-Y. Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. Diagn Microbiol Infect Dis. 2007; 58: 427-33.
19. Mímica LMJ, Ueda SMY, Martino MDV, Navarini A, Martini IJ. Diagnóstico de infecção por Candida: avaliação de testes de identificação de espécies e caracterização do perfil de suscetibilidade. J Bras Patol Med Lab. 2009; 45: 17-23.
20. Pinto PM, Weikert-Oliveira RCB, Lyon JP, et al. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis. Microbiol Res. 2008; 163: 579-85.
21. Lee SC, Lo HJ, Fung CP, Lee N, See LC. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole. J Microbiol Immunol Infect. 2009; 42: 148-53.
22. Pfaller MA, Hazen KC, Messer SA, et al. Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program. J Clin Microbiol. 2004; 42: 3607-12.
23. Cheng MF, Yu KW, Tang RB, et al. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis. 2004; 48: 33-7.
24. Yang YL, Ho YA, Cheng HH, Ho M, Lo HJ. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol. 2004; 25: 60-4.
25. Yang YL, Ho YA, Cheng HH, Lo HJ. Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan. Epidemiol Infect. 2005; 133: 325-30.
26. Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA. Drug resistance genes and trailing growth in Candida albi-cans isolates. J Antimicrob Chemother. 2004; 53: 217-24.